The Heavy Truth

The Heavy Truth

Nurse Practitioners Ben and Amy discuss their knowledge and experience in the medical weight management field.

  1. 2d ago

    S3 E14 - The Medicare Bridge Program: What It Is, Who Qualifies, and Why It's Confusing (But Doesn't Have to Be)

    This week on The Heavy Truth, Ben and Amy tackle one of the most common questions they're hearing in weight management: "How does the Medicare Bridge Program actually work?" If you've been trying to figure out coverage for GLP-1 medications or wondering what happens before Medicare starts paying (or doesn't), this episode breaks it all down in plain English. Along the way, Ben accidentally proves that time is just a social construct by referring to it being May, only for Producer Mike to quickly jump in with, "Ummm... it's June." That's what happens when you prerecord episodes and forget to check the calendar before hitting the mic. (For the record... it's actually July now. We promise we're better at insurance than dates.) The team walks through who may qualify for the Medicare Bridge Program, what it does and doesn't cover, common misconceptions, and the questions patients should be asking before making assumptions about their benefits. If Medicare coverage has left you scratching your head, this episode is for you. Because understanding your insurance shouldn't require a decoder ring. *Thanks for listening to The Heavy Truth! If you learned something, laughed at us for not knowing what month it is, or both, we'd call that a successful episode. Be sure to tune in next time for another dose of weight management, real talk, questionable jokes, and whatever month Ben thinks it is. Until then, stay healthy, stay curious, and remember... The truth might be heavy, but it doesn't have to be complicated. ~Ben and Amy

  2. Jun 8

    S3 E12 - Found-A-Yo Self a GLP-1 Pill

    This week on The Heavy Truth, Ben and Amy crack open the biggest obesity medicine news since someone looked at a weekly injection and said, "There has to be an easier way." Enter Foundayo™ (orforglipron) — Eli Lilly's brand-new oral GLP-1 weight loss pill. No needles. No refrigeration. No timing your breakfast like you're defusing a bomb. Just a once-daily tablet that can be taken anytime, with or without food or water. Ben and Amy break down: What exactly Foundayo is and how it worksWhy this isn't "Ozempic in a pill"The surprising science behind a GLP-1 tablet that doesn't require fastingThe ATTAIN-1 trial results, where patients lost an average of about 12.4% of their body weight, with some losing considerably more. How it compares to injectable medications like Zepbound and WegovyCommon side effects and who may be a good candidateThe pricing, insurance questions, and whether this could finally make obesity treatment more accessible to millions of people who never wanted an injection. Plus, Ben and Amy discuss the real question everyone's asking: If a GLP-1 shot becomes a GLP-1 pill, does your medicine cabinet officially become a weight-loss pharmacy? Whether you're needle-phobic, GLP-curious, or just wondering if "Foundayo" sounds more like a dance move than a medication, this episode delivers everything you need to know about the newest player in the obesity treatment game. Spoiler Alert: The future of weight management may fit in your pocket. "Take one tablet daily. Side effects may include reduced hunger, increased hope, and suddenly noticing how many commercials feature pizza." 🍕💊 #TheHeavyTruth #Foundayo #Orforglipron #GLP1 #WeightLoss #ObesityMedicine #Lilly #BenAndAmy #NoNeedlesNeeded

5
out of 5
7 Ratings

About

Nurse Practitioners Ben and Amy discuss their knowledge and experience in the medical weight management field.

You Might Also Like